Results 61 to 70 of about 177,501 (382)

Recognition and Initial Management of Fulminant Myocarditis

open access: yesCirculation, 2020
Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death resulting from cardiogenic shock, ventricular arrhythmias, or multiorgan system failure. Historically, FM was almost
R. Kociol   +9 more
semanticscholar   +1 more source

Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis

open access: yesRadiology, 2022
Background There are limited data on the pattern and severity of myocardial injury in patients with COVID-19 vaccination–associated myocarditis. Purpose To describe myocardial injury following COVID-19 vaccination and to compare these findings to other ...
Matteo Fronza   +7 more
semanticscholar   +1 more source

Sudden cardiac death caused by myocarditis in persons aged 1–49 years: a nationwide study of 14 294 deaths in Denmark

open access: yesForensic Sciences Research, 2019
Myocarditis is associated with an increased risk of sudden cardiac death (SCD) in the young. However, information on nationwide burden of SCD caused by myocarditis (SCD-myocarditis) is sparse.
Thomas Hadberg Lynge   +4 more
doaj   +1 more source

Identifying myocardial injuries in “normal-appearing” myocardium in pediatric patients with clinically suspected myocarditis using mapping techniques [PDF]

open access: yesPeerJ, 2020
Background Mapping techniques using cardiac magnetic resonance imaging have significantly improved the diagnostic accuracy for myocarditis with focal myocardial injuries.
Haipeng Wang   +9 more
doaj   +2 more sources

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

open access: yesNature Communications, 2022
Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19 mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a comprehensive assessment of the association, by vaccine and across sex and ...
S. Le Vu   +8 more
semanticscholar   +1 more source

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

open access: yesBritish medical journal, 2021
Objective To investigate the association between SARS-CoV-2 vaccination and myocarditis or myopericarditis. Design Population based cohort study. Setting Denmark.
A. Husby   +12 more
semanticscholar   +1 more source

Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature Review

open access: yesFrontiers in Cardiovascular Medicine, 2022
Acute myocarditis is a rare but serious complication associated with mRNA-based coronavirus disease 2019 (COVID-19) vaccination. In this article, four COVID-19 mRNA vaccination induced myocarditis cases managed at our tertiary Medical Center have been ...
Keita Watanabe   +19 more
doaj   +1 more source

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

open access: yesNature Reviews Cardiology, 2021
The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks.
S. Heymans, L. Cooper
semanticscholar   +1 more source

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors
Anju Nohria   +36 more
doaj   +1 more source

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin

open access: yesEuropean Heart Journal, 2020
BNP 139ng/L.
Hongde Hu   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy